Advertisement
Loading...

Bio-Rad Laboratories, Inc.

BIO-B•NYSE
Healthcare
Medical - Devices
$260.90
$0.90(0.35%)
U.S. Market opens in 37h 51m

Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio39.58
EPS (TTM)$6.01
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$266.26
3 Months$209.72
1 Year Target$88.35

BIO-B Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO-B) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $88.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.58 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.95%
5-Day Change
-3.29%
1-Month Change
-10.78%
3-Month Change
-3.86%
6-Month Change
-21.40%
Year-to-Date (YTD) Change
-20.46%
1-Year Change
-1.18%
3-Year Change
-33.90%
5-Year Change
-60.89%
All-Time (Max) Change
1782.90%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

7,700 Employees
IPO DateSep 21, 1999
CountryUS
Actively Trading

Frequently Asked Questions